Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/23/12 | ARS | Annual report to security holders |
|
71 | |
| 11/20/12 | 8-K | Current report filing |
|
2 | |
| 11/19/12 | DEF 14A | Definitive proxy statements |
|
46 | |
| 11/08/12 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
   |
4 |
| 10/25/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 10/17/12 | 8-K | Current report filing |
|
6 |
